These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2250567)

  • 1. S-emopamil ameliorates ischemic brain damage in rats: histological and behavioural approaches.
    Block F; Jaspers RM; Heim C; Sontag KH
    Life Sci; 1990; 47(17):1511-8. PubMed ID: 2250567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-emopamil protects against global ischemic brain injury in rats.
    Lin BW; Dietrich WD; Busto R; Ginsberg MD
    Stroke; 1990 Dec; 21(12):1734-9. PubMed ID: 2264081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats.
    Morikawa E; Ginsberg MD; Dietrich WD; Duncan RC; Busto R
    Stroke; 1991 Mar; 22(3):355-60. PubMed ID: 2003305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats.
    Block F; Pergande G; Schwarz M
    Brain Res; 1997 Apr; 754(1-2):279-84. PubMed ID: 9134985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach.
    Block F; Schwarz M
    Neuroscience; 1998 Feb; 82(3):791-803. PubMed ID: 9483536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.
    Bielenberg GW; Sauer D; Nuglisch J; Beck T; Rossberg C; Mennel HD; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):230-5. PubMed ID: 2725698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats.
    Block F; Schmitt W; Schwarz M
    J Neurol Sci; 1996 Aug; 139(2):167-72. PubMed ID: 8856648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does neuronal damage of CA1 relate to spatial memory performance of rats subjected to transient forebrain ischemia?
    Olsen GM; Scheel-Krüger J; Møller A; Jensen LH
    Acta Neurol Scand; 1994 Mar; 89(3):204-9. PubMed ID: 8030402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury.
    Busto R; Dietrich WD; Globus MY; Valdés I; Scheinberg P; Ginsberg MD
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):729-38. PubMed ID: 3693428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat.
    Nakayama H; Ginsberg MD; Dietrich WD
    Neurology; 1988 Nov; 38(11):1667-73. PubMed ID: 3185899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of ischemic neuronal damage in the dorsal hippocampus of rat.
    Schmidt-Kastner R; Hossmann KA
    Acta Neuropathol; 1988; 76(4):411-21. PubMed ID: 2459897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antioxidant LY 231617 ameliorates functional and morphological sequelae induced by global ischemia in rats.
    Block F; Schmitt W; Schwarz M
    Brain Res; 1995 Oct; 694(1-2):308-11. PubMed ID: 8974659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow.
    Sauer D; Nuglisch J; Rossberg C; Mennel HD; Beck T; Bielenberg GW; Krieglstein J
    Neurosci Lett; 1988 Sep; 91(3):327-32. PubMed ID: 3185970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinconate prevents ischemic neuronal damage in the rat hippocampus.
    Araki T; Nishioka K; Yuki S; Kogure K
    Acta Neurol Scand; 1990 Feb; 81(2):173-6. PubMed ID: 2327239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia.
    Kiyota Y; Miyamoto M; Nagaoka A
    Brain Res; 1991 Jan; 538(2):295-302. PubMed ID: 2012971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists in the treatment of experimental cerebral ischemia.
    Ginsberg MD; Lin B; Morikawa E; Dietrich WD; Busto R; Globus MY
    Arzneimittelforschung; 1991 Mar; 41(3A):334-7. PubMed ID: 1859503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral performance of rats following transient forebrain ischemia.
    Volpe BT; Pulsinelli WA; Tribuna J; Davis HP
    Stroke; 1984; 15(3):558-62. PubMed ID: 6729888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats.
    Okada M; Amamoto T; Tomonaga M; Kawachi A; Yazawa K; Mine K; Fujiwara M
    Neuroscience; 1996 Mar; 71(1):17-25. PubMed ID: 8834389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.